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Conflicts of interest for medical publishers and
editors: Protecting the integrity of scientific
scholarship
Sapan S. Desai, MD, PhD,a and Cynthia K. Shortell, MD,b Durham, NC
Competition of interest may exist at all levels in the medical publication process. Ensuring the integrity of scientific
scholarship involves protecting editorial independence, promoting the use of scientific arbitration boards, promoting
transparency throughout all stages of publication, and protecting the relationship between the publisher and its editors
through an effective legal framework. It is incumbent upon the publisher, editors, authors, and readers to ensure that the
highest standards of scientific scholarship are upheld. Doing so will help reduce fraud and misrepresentation in medical
research and increase the trustworthiness of landmark findings in science. ( J Vasc Surg 2011;54:59S-63S.)
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iCompetition of interest issues have received much at-
tention from the government, media, and scientific com-
munities recently. Of particular interest has been scientific
inquiry in which financial conflicts, sometimes combined
with incomplete or improper disclosure, lead to the percep-
tion (or reality) that the study results may be biased or
inaccurate.1-4 Additionally, past abuse of federal health care
funds has led to fines and incarceration for the most egre-
gious offenders.5
Competition of interest and errors in their disclosure
range from the innocent to the criminal. In some cases, the
conflicting interest may interfere with the impartiality and
integrity of the scientific endeavor. For authors, this may
mean failure to disclose a financial conflict in the hopes that
publication of a particular study will bring fortune.6,7 In
other instances, grant support by industry partners has been
associated with the publication of proindustry results.8
Such conflicts of interest between an author and the pub-
lished study are discussed elsewhere in this Journal and the
medical literature.
A topic that has received far less attention is the poten-
tial for serious conflicts of interest between editors, contrib-
uting authors, the publisher, and advertisers (Fig 1).9-11
While authors are primarily interested in their manuscript,
editors of major journals routinely interface with a much
broader group and, therefore, may be more susceptible to
bias and potential influence. For example, advertisers who
wish to have a particular ad incorporated into a journal issue
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doi:10.1016/j.jvs.2011.05.111ay approach one of the editors of a journal. Hypotheti-
ally, that editor may be more inclined to accept a study
hat deals with a product being sold by the advertiser, or
eject an article that discusses negative findings about the
roduct. Editors may then potentially coerce the publisher
o place the ad next to the favorable study. These paid
lacements may lead to greater profits for the journal and
ome reward for the editor. The peer-review process
hereby breaks down and the standards of scientific schol-
rship are sacrificed for material gain.
This article discusses these potential conflicts of interest
rom the publishing aspect of medical scholarship: editors
nd publishers must be as responsible as authors to pro-
ote and protect the integrity of the scientific process. As
he final gateway in the publishing process, editors in
articular must be vigilant against these trespasses and
nsure that the content of medical publications is entirely
ndependent of all personal, institutional, and corporate
nfluence. This responsibility can be achieved by protecting
ditorial independence, promoting the use of a scientific
rbitration board for serious disputes, promoting transpar-
ncy throughout all stages of publication, and taking ad-
antage of an effective legal framework via contracts and
greements to protect scientific scholarship.
OLE OF EDITORS
By overseeing the process of peer-review, editors influ-
nce the selection of reviewers and adjudicate feedback
iven to the authors. Bias within this process may make a
anuscript more or less likely to be accepted. In other
ases, editors who have a research interest closely aligned to
particular manuscript will have advanced access to unpub-
ished data and findings that may influence their work. This
ay lead to an unfair advantage in concurrent grant appli-
ations, or even outright rejection of the manuscript to
reserve their scientific advantage.
The currency of academicians is the number and quality
f peer-reviewed publications: they promote their rise in
cademic channels, help obtain grant funding, and gain
nfluence. As the key decision makers on articles, editors
nfluence the careers of their authors by determining the
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September Supplement 201160S Desai and Shortellfate of their submissions. Accepting or rejecting such arti-
cles can thereby influence opportunities to obtain grant
funding and academic advancement.12,13
In addition to working with authors, editors also inter-
act closely with the publisher. Print deadlines, manuscript
requirements, copyright waivers, disclosures, author agree-
ments, copyediting, proofing, and many more details con-
tinuously influence the relationship between editors and
publishers.
Finally, editors also have the opportunity to interface
with advertisers. It is likely that the business and profes-
sional affiliates of editors will be aware of their role in an
influential journal.14,15 These relationships create a poten-
tial conflict of interest resulting from inappropriate influ-
ence over the peer-review process, including promotion of
relevant products within journal articles, favoring manu-
scripts that support the advertizer, advance distribution of
journal issue contents to afford the opportunity for simul-
taneous advertising or other unfair advantages.16,17
ROLE OF THE PUBLISHER
Publishers of medical journals have a vested financial
interest in the journal. They are charged with providing an
instrument through which scientific findings are communi-
cated to an educated audience. Publishers work directly
with advertisers to ensure that their journal remains sustain-
able. Through their financial resources, they are able to
provide administrative support for the journal while con-
tinuing to develop their circulation and content.
Publishers enable authors, editors, and readers to com-
municate by providing a neutral platform. In today’s digital
workflow, this streamlines manuscript submission, expe-
dites peer-review, and leads to a faster turnover time while
increasing convenience for all involved parties. Once a
Fig 1. Potential conflicts of interest between authors, editors,
publisher, advertisers, and readers. Only the potential conflicts
between advertisers and the other parties are shown, but there are
issues that can arise between any of the parties. Readers are the
central focus of the publication process, but one could easily
substitute patients in lieu of readers.manuscript has been accepted for publication, the publisher completes the copyediting process and converts the manu-
cript into the final published form.
If editors determine which articles should be published,
he publisher determines how they will be printed and
istributed. Publishers may coerce editors to accept or
eject certain manuscripts, especially if they are not congru-
nt with other interests the publisher may have.18 Certain
esign or printing constraints may affect the particular
rrangement or appearance of an article.
Publishers work closely with their editors to maintain
he scientific and ethical integrity of the journal. However,
his relationship also creates the opportunity to influence
hether certain manuscripts are accepted or rejected. De-
ending on the particular constraints of the journal, pub-
ishers may pressure editors to reject manuscripts that dis-
uss controversial topics, publish findings that are counter
o the financial interests of the publisher, or do notmeet the
articular design requirements of the journal.
Publishers are also charged with seeking opportunities
o increase their readership and overall circulation. For
any journals, greater circulation leads to greater promi-
ence and financial gain. The selection and placement of
dvertising, articles, and various design elements may influ-
nce this readership. Particularly controversial articles may
ead to a decline in circulation or negative media attention.
ublishers who are part of companies that conduct business
n other areas of medicine may be particularly pushed to
ngage editors over certain articles.19
OTENTIAL CONFLICTS OF INTEREST
These complex relationships between authors, editors,
ublishers, advertisers, and readers create the opportunity
or conflicts of interest that threaten the integrity of scien-
ific scholarship. These conflicts extend well beyond the
cientific and ethical issues that exist between authors and
heir manuscripts. Potential abuse of these relationships
ntroduces a variable for which there has not yet been a
ignificant conversation in the medical literature.
EER-REVIEW PROCESS
There remains some debate as to whether the peer-
eview process should be double-blind, single-blind, or if it
hould be blinded at all.20-24 Several major journals have
pted to forgo blinding and instead keep all authors, affil-
ations, and manuscript reviewers out in the open. By
ublishing this information, any potential conflicts of inter-
st are made available for external review. The rationale is
hat any disclosures or conflicts between editors and the
anuscripts they review will be avoided. While the results
hus far have been satisfactory,23,25 open review does not
olve the issue of editors potentially gaining benefit in the
uture via a quid pro quo transaction with the authors in
uture academic endeavors.26 Further, there may be some
ressure to accept manuscripts from influential and power-
ul authors, as rejection of a manuscript or negative feed-
ack may sever relationships, lead to animosity, or reper-
ussions.
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Volume 54, Number 18S Desai and Shortell 61SDouble-blinding the peer-review process reduces the
likelihood of such quid pro quo transactions and also
promotes more complete positive and negative feedback
to authors. To maintain the fidelity of this process, this
double-blind peer-review should be supervised by the
Editor-in-Chief. The primary role of the Editor-in-Chief
should be to ensure that the appropriate editors and review-
ers will receive the manuscript for review, and that these
reviewers will not be in a position to unduly benefit or
influence the work at hand. The reviewers will serve as a
system of checks and balances, as they will ultimately be-
come aware of the identities of the authors whose work they
reviewed should it reach the publication stage. This ar-
rangement avoids self-policing, preserves the integrity of
peer-review, and reduces bias by editors and authors. By
assigningmanuscripts through the Editor-in-Chief, review-
ers with a closely aligned research interest or other corrupt-
ible conflict of interest are excluded immediately. Limita-
tions of this process must be recognized: in many cases
authors and institutions can be recognized by the manu-
script content, the blinding process is not watertight, and
new findings can still be poached even if the authors’
identities are not known.
EDITORIAL INDEPENDENCE
Editors are in a unique position to be influenced by a
variety of competing interests. Editors have a responsibility
to preserve the integrity of scientific scholarship through
maintenance of the peer-review process and uphold high
ethical standards. These interests may occasionally compete
with desires manifest by the publisher, societal sponsors,
advertisers, authors, and readers.
To ensure that editors are able to make their decisions
without significant coercion, they should be protected by a
legal framework that preserves their independence within
Fig 2. Checks and balances between authors, editors, pu
and editor should preserve editorial independence wi
statements, a clear conflict of interest policy, and double-b
and authors. Finally, readers can trust the peer-review pro
publication process is transparent. A scientific arbitratio
representative authors and readers should be formed tothe physical limitations of the journal (Fig 2).27-29 Further- gore, their duty to the high standards of scientific scholar-
hip should be protected by limiting their role in dealing
ith entities that may influence the peer-review process.
ditors should not have any role in recruiting, selecting, or
lacing advertising within a journal. This entire process
hould be controlled by the publisher (who in turn has no
nfluence over scientific content of the journal). Removing
ditors from this role entirely mitigates the potential for
iasing the selection of manuscripts and potentially inap-
ropriate benefits from working with industry partners in
he capacity of an editor.30 In addition, the publication’s
dvertising staff should not have advance knowledge of the
ontent of a journal issue to eliminate the opportunity of
nfluencing advertising content.
A legal contract should be in place between the pub-
isher and the editors that guarantees their independence
nless there are exceptional circumstances. Editors should
e appointed for a fixed term and should be permitted to
ake independent decisions regarding the selection, inclu-
ion, and arrangement of articles within the design limita-
ions of the journal. While the publisher is inherently
esponsible for the stylistic and formatting conditions, the
nal layout of an article should be done in conjunction with
he editors and authors.
Such a legal framework also protects editors from being
nfluenced by societal sponsors and demands that the pub-
isher may have from time to time. The inclusion of certain
rticles should be left entirely up to the editors in conjunc-
ion with the peer-review process. Publishers provide a
aluable instrument to communicate important scientific
ndings; as part of the separation of powers, editors should
e the ones who determine what those findings will be.
CIENTIFIC ARBITRATION BOARD
Occasionally, there will be serious challenges to the
er, and readers. Legal agreements between the publisher
he publication constraints of the journal. Disclosure
d peer-review can help prevent conflicts between editors
nd content they read by ensuring that the entire scientific
ard composed of the publisher and editors along with
djudicate major issues.blish
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September Supplement 201162S Desai and Shortellmajor journals take today against fraud and corruption, no
one is immune from a perversion of the scientific process.
Major conflicts of interest, ethical dilemmas, and other
major issues should be resolved by a scientific arbitration
board composed of editors and publishers (Fig 2). If perti-
nent, authors and readers should be invited to participate in
the proceedings. Such a board serves as a final method of
checks and balances against the publisher and editors; the
decisions of this board should be binding upon all parties.
Such a board provides a unique opportunity to con-
front authors involved with plagiarism, data fabrication,
and other major violations of scientific trust. It provides a
forum to challenge editors who may have been involved in
questionable decision-making or who may have trespassed
upon the ethical and scientific standards of the journal. It
also serves to notify the publisher, advertisers, and readers
of any potential breaches in scientific scholarship. By incor-
porating all of the parties with a vested interest in such a
board, it becomes capable of dealing with even the most
challenging issues that face a journal.
CONFLICTS INVOLVING THE
EDITOR-IN-CHIEF
The Editor-in-Chief serves as the public face of the
journal and the final authority on all its scientific matters.
Yet, even theymay be placed in positions where a conflict of
interest exists, either between them and a paper under
review, with other editors, or even with the publisher.
Objectivity is the key to maintaining high standards of
scientific scholarship; if such objectivity of an Editor-in-
Chief is compromised, he must recuse himself from the
decision-making process and assign the task to a managing
editor.
Managing editors should be appointed such that their
potential conflicts of interests are not similar to that of the
Editor-in-Chief so that they can help resolve situations
from which the Editor-in-Chief must be recused. In situa-
tions where the conflict of interest cannot be resolved by
the managing editor, important decisions should then be
undertaken by the scientific arbitration board. The key to
protecting the publication process is to make all major
decisions transparent. Hasty decisions made when conflicts
of interest are present can present serious legal issues due to
the financial and societal repercussions that can occur.
LEGAL ISSUES
In 2006, a prominent South Korean scientist was in-
dicted for embezzlement and scientific fraud and sentenced
to a short prison term.31 Dr Hwang made headlines when
he published two papers in Science that described his re-
search on patient-specific stem-cells derived from embryos
that could be used for stem cell transplants.32,33 This past
year, a prominent researcher at Harvard was found guilty of
eight counts of scientific misconduct. A paper in a promi-
nent psychology journal was retracted, and there is an
ongoing investigation by the US Attorney’s Office for the
District of Massachusetts.34 In November 2010, a promi-
nent cancer researcher at DukeUniversity resigned from his rost following the retraction of an important paper and
essation of clinical trials that were based on questionable
ata.35,36 Questions regarding his credentials have also led
o an investigation from the American Cancer Society as to
hether grants obtained by that society were under false
retenses.36
Major conflicts of interest may be manifest in extreme
ays that violate local, state, or federal statutes that may be
unishable by fines and/or incarceration. In USA vs Poehl-
an (2006), Dr Poehlman made a plea bargain with pros-
cutors to serve 1 year and a day in jail for fabricating data
n 10 different papers and falsifying grant applications to
he National Institutes of Health (NIH) related to hor-
one replacement therapy for menopause.37While making
imple mistakes is unlikely to lead to an allegation of
cientific misconduct (cf NIH Office of Research Integrity
isconduct statement), intentional data fabrication, fraud,
nd embezzlement are likely to get the attention of author-
ties.
As these issues take on more importance, it is incum-
ent upon editors and publishers to identify instances of
cientific misconduct prior to publication, and to more
ggressively handle cases as they come to light. For in-
tance, communicating with all authors of a manuscript
nstead of just the submitting author can help ensure that all
uthors are aware of the nature and content of the publica-
ion. Having access to the original data, particularly for
andmark publications, can help foster scientific oversight;
his is particularly noteworthy in our time given our ready
ccess to rich media over the Internet. Simultaneously
ublishing such original data online in conjunction with
he paper can help eliminate doubt while furthering scien-
ific scholarship. Finally, to avoid ambiguity when these
ssues arise, a concerted effort between the publisher and its
ditors should be made to publish disclosures of conflicts of
nterest, conflict of interest policies, a statement on the
tandards of scientific scholarship, and so forth.
There are also legal issues that can exist between the
ublisher and its editors. Relationships between these two
ntities should be protected in the form of a contract. Such
written statement also helps to clarify the responsibilities
f the two entities, and promotes transparency in this
mportant relationship. Such a legal framework protects
oth publishers and editors; an effective policy will not
inder the free and open exchange of ideas nor impede
cientific scholarship.
AINTENANCE OF SCIENTIFIC INTEGRITY
Potential conflicts of interest exist at all stages in pub-
ishing. The highest standards of scientific scholarship
hould be upheld, but readers, authors, editors, and pub-
ishers are all equal partners in this endeavor. By instituting
ransparency with regard to peer-review, decision-making,
nd internal journal processes, the entire process of scien-
ific publication becomes more trustworthy and less suscep-
ible to outside influence. Scientific arbitration boards can
elp adjudicate major conflicts while protecting the integ-
ity of the publisher and journal editors.
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Volume 54, Number 18S Desai and Shortell 63SEditorial independence within the physical constraints
of the journal promotes a free and open exchange of ideas
unhampered by the economics of running a medical pub-
lication. Combined with transparency and a legal frame-
work to protect publishers and editors, undue influence by
advertisers and competing interests can be minimized.
There have been a number of challenges to scientific
integrity in recent years.Without aggressive intervention by
editors and publishers, the public’s confidence in scientific
scholarship will falter. This may lead to a shift in priorities in
funding for medical research, impede research endeavors,
and delay timely care that we provide to our patients.
Further, if there is not a thoughtful and effective framework
in place for publishers to deal with these issues, we may find
ourselves policed by external entities that do not appreciate
all of the finer points of medical research.
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